| 2008 Scleroderma
Foundation Research Grant Awardees |
| Investigator |
Institution |
Project Title |
Grant Duration |
Amt Granted |
| Mehrdad Abedi, M.D. (est.) |
Roger Williams Hospital, Providence, R.I. |
Hematopoietic Origin of Fibroblasts at Sites of Injury |
Two years |
$150,000 |
| Sandeep Krishna Agarwal, M.D., Ph. D.
(new) |
University of Texas Health Science Center, Houston, Texas |
Role of Cadherin-11 in Dermal Fibrosis |
Three years |
$150,000 |
| Stephen Clark, Ph.D. (est.) |
University of Connecticut Health Center, Farmington, Conn. |
Impact of the Ablation of TGF-B Signaling and
SPARC Protein on the Fibrotic Phenotype in the
TSK-2 Mutant Mouse |
Two years |
$150,000 |
| Patrizia Fuschiotti, Ph.D. (new) |
University of Pittsburgh, Pittsburgh, Pa. |
Genetic Control of Cytokine Production by Human
CD-8+ and CD4+ T cells in Systemic Sclerosis (SSc) |
Three years |
$150,000 |
| Maria Trojanowska, M.Sc., Ph.D. (est.) |
Medical University of South Carolina, Charleston, S.C. |
The Role of Fli1 in Scleroderma Vasculopathy |
Two years |
$150,000 |
| Daniel J. Tschumperlin, BSME, MSE, Ph.D. (est.) |
Harvard School of Public Health, Boston, Mass. |
Regulation of Dermal Fibroblast Biology by
Substrate Stiffness |
Two years |
$150,000 |
| Heather N. Yeowell, Ph.D. (est.) |
Duke University, Durham, N.C. |
Regulation of Collagen Lysine Hydroxylation in
Scleroderma Fibroblasts; Linkage of Alternatively-
Spliced Forms of Lysyl Hydroxylase 2 to Fibrosis |
Two years |
$150,000 |
| |
|
|
Total Granted: |
$1,050,000
|
